査読有
doi：10.1111/hepr.14193
PubMed No.：40317810
2023 Impact Factor：3.9
種類：原著
誌名：Hepatology Research
発行年月：2025年4月
巻号頁：in press
論題：Efficacy and safety of lenvatinib-transcatheter arterial chemoembolization sequential therapy for hepatocellular carcinoma within the up-to-seven criteria
著者：Shigeo Shimose, Takashi Niizeki, Hideki Iwamoto, Masatoshi Tanaka, Etsuko Moriyama, Tomotake Shirono, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
